Both Mounjaro and Wegovy work by mimicking gut hormones, and both come with a broadly similar bag of side effects. So the honest answer to "which one is easier on the stomach?" is: for most people, not very different. But there are real distinctions worth knowing before you start.
This page compares Mounjaro vs Wegovy side effects the way we compare everything on this site: evidence first, no favourites, no pretending a prescription jab is risk-free. Whether either is right for you is a decision for a prescriber, not a website.
The common side effects overlap almost completely — nausea, diarrhoea, constipation and vomiting lead both lists. The biggest lever on how badly you feel them is the same for both drugs: starting low, going up slowly, and not rushing the dose. The rare serious risks differ in the detail, which is exactly why a prescriber weighs your history before choosing.
The side effects Mounjaro and Wegovy share
Mounjaro (tirzepatide) and Wegovy (semaglutide) belong to the same broad family. Wegovy is a GLP-1 receptor agonist; Mounjaro is a dual GIP and GLP-1 agonist. Both slow how quickly the stomach empties and dial down appetite — and that shared mechanism produces a shared set of gut symptoms.
For both medicines, the most common side effects are gastrointestinal:
- Nausea — the headline complaint for both. On Wegovy it affects roughly 40% of people at some point.
- Diarrhoea
- Constipation
- Vomiting
Mounjaro's common list also flags tiredness; Wegovy's flags headache. Most of these are dose-related, most are worst in the first days after a dose increase, and most settle as your body adjusts. They are the reason both drugs are deliberately started at a low "starter" dose that is not yet a treatment dose.
Where the two differ
The overlap is large, but not total. Two things genuinely separate the side-effect experience.
1. How fast you climb the dose ladder
Side effects track dose escalation, so the schedule matters. Wegovy is titrated gradually over about 16 weeks — 0.25 mg weekly for four weeks, then 0.5, 1 and 1.7 mg, reaching the usual 2.4 mg maintenance dose from around week 17. Mounjaro starts at 2.5 mg weekly for four weeks, then 5 mg, then steps up in 2.5 mg increments after at least four weeks each, up to a maximum of 15 mg.
Neither schedule is "gentler" in the abstract. Both share the same rule: each step is spaced out so your gut has time to adapt before the next increase. Pushing the dose faster than the label allows is the most reliable way to make either drug feel worse.
2. The rare serious risks
Behind the common nuisance symptoms sit rarer, more serious risks. Here the two labels diverge in the detail — and this is the part a prescriber studies against your medical history.
| Serious risk (rare) | Mounjaro (tirzepatide) | Wegovy (semaglutide) |
|---|---|---|
| Pancreatitis | Listed (rare) | Listed (rare) |
| Gallstones / gallbladder problems | Listed | Listed |
| Dehydration & kidney strain | Listed — from vomiting/diarrhoea | Risk shared via gut symptoms |
| Low blood sugar | With insulin or a sulfonylurea | In people with type 2 diabetes |
| Rare eye condition (NAION) | Not on the tirzepatide list | Listed for semaglutide |
The pattern to notice: pancreatitis and gallstones appear on both. Dehydration is really a downstream effect of the shared gut symptoms. The one label-level difference worth flagging is NAION, a rare eye condition listed for semaglutide (Wegovy). These are uncommon, but they are the reason you report anything unexpected rather than pushing through it.
Severe, persistent stomach pain — especially pain that spreads to your back — needs urgent medical attention, as it can signal pancreatitis. So does any sudden change in vision. If you suspect a side effect from either medicine, tell your prescriber and report it through the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk.
Who each jab is not for
Side effects are only half the safety picture. Some people should not take these medicines at all, and the exclusion lists differ slightly.
Mounjaro is not for people who are pregnant or planning pregnancy, anyone with an allergy to tirzepatide, or those under 18. Caution applies with a history of pancreatitis, severe gut disease, or diabetic eye disease.
Wegovy is not for people who are pregnant or breastfeeding, anyone with an allergy to semaglutide, people with type 1 diabetes, or those with a history of medullary thyroid cancer or MEN2 (per US labelling). Caution applies with a history of pancreatitis or severe gut disease.
This is exactly why the prescriber, not the patient and not a website, decides. A free consultation with a regulated provider is where your history gets matched against these lists.
Starting either jab? Start it with a prescriber who checks in
Side effects are easiest to manage when someone is actually watching your dose. The Weight Clinic is our recommended provider: a GPhC-registered pharmacy with a free consultation, monthly video reviews to catch problems early, and a refund if you are declined. Use code NEWME for £35 off your first order. Prices and availability are set by the provider — confirm on their site.
Visit The Weight Clinic →How to make side effects easier — on either drug
Most of what helps applies equally to both drugs, because the mechanism is so similar:
- Respect the titration schedule. The slow dose climb exists for this exact reason. Don't ask to skip steps.
- Eat smaller, slower meals. Because both drugs slow stomach emptying, large or fatty meals are far more likely to trigger nausea.
- Stay hydrated. This blunts constipation and protects your kidneys if you do get diarrhoea or vomiting.
- Expect the worst days just after a dose increase, then improvement as you settle at that dose.
- Flag anything that isn't settling. A good provider can slow your titration or hold a dose — which is far easier if someone is reviewing you monthly.
So which has "fewer" side effects?
Head-to-head, there is no clean winner on tolerability for the average person — the common side effects are nearly identical, and individual experience varies more than the two drugs do. What differs is the fine print: the titration schedules, and a handful of label-level distinctions in the rare serious risks, most notably NAION on the Wegovy side.
Side effects are one round of a longer fight. For how the two compare on weight loss, see Mounjaro vs Wegovy results; on cost, see Mounjaro vs Wegovy price; and for everything scored together, the full comparison. If you are already on Wegovy and weighing a move, read switching from Wegovy to Mounjaro. You can also compare live prices from regulated pharmacies on our homepage table.
Frequently asked questions
Does Mounjaro have fewer side effects than Wegovy?
Not in any clear-cut way. Both share the same common side effects — nausea, diarrhoea, constipation and vomiting — and individual tolerance varies more than the two medicines do. There isn't a reliable "gentler" option for the average person; the honest comparison is that they are broadly similar, with small differences in the rare serious risks and the dose schedule.
How long do the side effects last?
For most people the gut symptoms are worst in the first few days after starting or after each dose increase, then ease as the body adjusts. Because both drugs are titrated up over weeks, you may notice a flare each time the dose rises, followed by settling. Persistent symptoms should be raised with your prescriber.
What is the most common side effect of each?
Nausea leads both lists. For Wegovy it affects around 40% of people at some point. Mounjaro's most common effects are nausea, diarrhoea, constipation, vomiting and tiredness; Wegovy's are nausea, diarrhoea, vomiting, constipation and headache.
Are there any serious side effects I should watch for?
Both list pancreatitis (rare) and gallstones. Severe stomach pain, especially pain spreading to the back, needs urgent medical attention. Semaglutide (Wegovy) additionally lists NAION, a rare eye condition, so any sudden vision change should be checked promptly. Report suspected side effects via the MHRA Yellow Card scheme.
Can I switch drugs if the side effects are too much?
That's a conversation for your prescriber. Because both medicines share the same core side effects, switching isn't guaranteed to solve tolerability, but adjusting the dose, slowing the titration, or reviewing how you eat often helps first. If a switch is being considered, our guide on switching from Wegovy to Mounjaro covers what's involved.
Compare, then decide with a clinician
Neither jab is risk-free, and the right choice depends on your history and how you tolerate it. The Weight Clinic — our recommended provider — offers a free consultation, monthly video reviews, and a refund if you're declined. Code NEWME takes £35 off your first order. This is comparison and price information, not medical advice; confirm details and suitability with the provider and your GP.
Visit The Weight Clinic →